CIK: 1619252 - Address: C/O Allovir, Inc., 1100 Winter Street, Waltham, MA 02451
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/7/24 16:15
5/3/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-20.79600-20510D
4/23/24 16:15
4/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-10.75030-10512D
4/4/24 16:15
4/2/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.7720000513D
2/22/24 16:16
2/20/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.6952000514D
2/6/24 16:40
2/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-60.67000-9-2514D
1/25/24 16:15
1/23/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-10.67080-10523D
1/8/24 16:15
1/4/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS00.6390000524D
1/23/23 19:00
1/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.m-135.090-3-1437M
11/16/22 17:10
11/14/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-218.910-2-1440I
10/26/22 16:15
10/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS.a-59.360-10249D
10/24/22 18:24
10/19/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagMiller EdwardMAOGCS-59.360-10442D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact